AstraZeneca PLC to Pay $68.5 Million to U.S. States Over Seroquel Marketing

March 11, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- AstraZeneca Plc (AZN) agreed to pay $68.5 million to 37 U.S. states and the District of Columbia to resolve allegations that the company deceptively marketed its anti-psychotic drug Seroquel.

Twitter
LinkedIn
Facebook
Email
Print

Legal

AstraZeneca Pharmaceuticals LP